Logo image of CRBD

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) Stock Fundamental Analysis

USA - NYSE:CRBD - US21871X2080

24.72 USD
+0.22 (+0.9%)
Last: 11/14/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, CRBD scores 4 out of 10 in our fundamental rating. CRBD was compared to 97 industry peers in the Financial Services industry. There are concerns on the financial health of CRBD while its profitability can be described as average. CRBD has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CRBD had positive earnings in the past year.
CRBD had a positive operating cash flow in the past year.
CRBD had positive earnings in each of the past 5 years.
CRBD had a positive operating cash flow in each of the past 5 years.
CRBD Yearly Net Income VS EBIT VS OCF VS FCFCRBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

1.2 Ratios

CRBD has a worse Return On Assets (0.24%) than 68.04% of its industry peers.
CRBD's Return On Equity of 7.32% is in line compared to the rest of the industry. CRBD outperforms 40.21% of its industry peers.
Industry RankSector Rank
ROA 0.24%
ROE 7.32%
ROIC N/A
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)N/A
ROIC(5y)N/A
CRBD Yearly ROA, ROE, ROICCRBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

CRBD has a Profit Margin (5.64%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CRBD has grown nicely.
CRBD's Operating Margin of 12.90% is in line compared to the rest of the industry. CRBD outperforms 48.45% of its industry peers.
CRBD's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.9%
PM (TTM) 5.64%
GM N/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
CRBD Yearly Profit, Operating, Gross MarginsCRBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

2

2. Health

2.1 Basic Checks

CRBD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CRBD has been reduced compared to 1 year ago.
The number of shares outstanding for CRBD has been reduced compared to 5 years ago.
The debt/assets ratio for CRBD is higher compared to a year ago.
CRBD Yearly Shares OutstandingCRBD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
CRBD Yearly Total Debt VS Total AssetsCRBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

CRBD has a debt to FCF ratio of 6.80. This is a slightly negative value and a sign of low solvency as CRBD would need 6.80 years to pay back of all of its debts.
The Debt to FCF ratio of CRBD (6.80) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.81 indicates that CRBD is somewhat dependend on debt financing.
CRBD's Debt to Equity ratio of 0.81 is in line compared to the rest of the industry. CRBD outperforms 47.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 6.8
Altman-Z N/A
ROIC/WACCN/A
WACC6.24%
CRBD Yearly LT Debt VS Equity VS FCFCRBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CRBD Yearly Current Assets VS Current LiabilitesCRBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

6

3. Growth

3.1 Past

CRBD shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.29%.
Measured over the past years, CRBD shows a very strong growth in Earnings Per Share. The EPS has been growing by 115.54% on average per year.
The Revenue has grown by 20.58% in the past year. This is a very strong growth!
Measured over the past years, CRBD shows a quite strong growth in Revenue. The Revenue has been growing by 8.01% on average per year.
EPS 1Y (TTM)1.29%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%-30.43%
Revenue 1Y (TTM)20.58%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%24.11%

3.2 Future

Based on estimates for the next years, CRBD will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.99% on average per year.
Based on estimates for the next years, CRBD will show a small growth in Revenue. The Revenue will grow by 2.61% on average per year.
EPS Next Y-2.56%
EPS Next 2Y7.69%
EPS Next 3Y11.02%
EPS Next 5Y10.99%
Revenue Next Year-10.4%
Revenue Next 2Y-2.8%
Revenue Next 3Y0.65%
Revenue Next 5Y2.61%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRBD Yearly Revenue VS EstimatesCRBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
CRBD Yearly EPS VS EstimatesCRBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.25, the valuation of CRBD can be described as very cheap.
Based on the Price/Earnings ratio, CRBD is valued cheaper than 93.81% of the companies in the same industry.
CRBD is valuated cheaply when we compare the Price/Earnings ratio to 25.89, which is the current average of the S&P500 Index.
CRBD is valuated cheaply with a Price/Forward Earnings ratio of 4.40.
Based on the Price/Forward Earnings ratio, CRBD is valued cheaper than 90.72% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CRBD to the average of the S&P500 Index (34.59), we can say CRBD is valued rather cheaply.
Industry RankSector Rank
PE 5.25
Fwd PE 4.4
CRBD Price Earnings VS Forward Price EarningsCRBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRBD is valued a bit cheaper than the industry average as 73.20% of the companies are valued more expensively.
CRBD's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CRBD is cheaper than 77.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.22
EV/EBITDA 8.81
CRBD Per share dataCRBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.05
EPS Next 2Y7.69%
EPS Next 3Y11.02%

3

5. Dividend

5.1 Amount

CRBD has a Yearly Dividend Yield of 3.20%. Purely for dividend investing, there may be better candidates out there.
CRBD's Dividend Yield is a higher than the industry average which is at 4.50.
CRBD's Dividend Yield is a higher than the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 3.2%

5.2 History

CRBD does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

52.57% of the earnings are spent on dividend by CRBD. This is a bit on the high side, but may be sustainable.
DP52.57%
EPS Next 2Y7.69%
EPS Next 3Y11.02%
CRBD Yearly Income VS Free CF VS DividendCRBD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B
CRBD Dividend Payout.CRBD Dividend Payout, showing the Payout Ratio.CRBD Dividend Payout.PayoutRetained Earnings

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64

NYSE:CRBD (11/14/2025, 8:04:00 PM)

24.72

+0.22 (+0.9%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)02-10 2026-02-10/amc
Inst Owners86.58%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap13.31B
Revenue(TTM)17.58B
Net Income(TTM)991.00M
Analysts79.05
Price Target33.82 (36.81%)
Short Float %0%
Short Ratio0.36
Dividend
Industry RankSector Rank
Dividend Yield 3.2%
Yearly Dividend0.92
Dividend Growth(5Y)N/A
DP52.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.09%
Min EPS beat(2)-9.38%
Max EPS beat(2)15.55%
EPS beat(4)2
Avg EPS beat(4)1.6%
Min EPS beat(4)-9.38%
Max EPS beat(4)15.55%
EPS beat(8)6
Avg EPS beat(8)3.78%
EPS beat(12)9
Avg EPS beat(12)6.23%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-11.42%
Max Revenue beat(2)9.43%
Revenue beat(4)1
Avg Revenue beat(4)-7.19%
Min Revenue beat(4)-14.87%
Max Revenue beat(4)9.43%
Revenue beat(8)2
Avg Revenue beat(8)-15.26%
Revenue beat(12)4
Avg Revenue beat(12)-10.8%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.81%
PT rev (3m)16.02%
EPS NQ rev (1m)-13.26%
EPS NQ rev (3m)-18.11%
EPS NY rev (1m)-6.01%
EPS NY rev (3m)-4.75%
Revenue NQ rev (1m)2.17%
Revenue NQ rev (3m)-0.58%
Revenue NY rev (1m)-3.14%
Revenue NY rev (3m)-7.61%
Valuation
Industry RankSector Rank
PE 5.25
Fwd PE 4.4
P/S 0.76
P/FCF 8.22
P/OCF 8.22
P/B 0.98
P/tB 0.98
EV/EBITDA 8.81
EPS(TTM)4.71
EY19.05%
EPS(NY)5.61
Fwd EY22.71%
FCF(TTM)3.01
FCFY12.16%
OCF(TTM)3.01
OCFY12.16%
SpS32.65
BVpS25.15
TBVpS25.15
PEG (NY)N/A
PEG (5Y)0.05
Graham Number51.62
Profitability
Industry RankSector Rank
ROA 0.24%
ROE 7.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 12.9%
PM (TTM) 5.64%
GM N/A
FCFM 9.21%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.38%
ROCE(5y)1.27%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 6.8
Debt/EBITDA 4.06
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 3.58
Cash Conversion 59.72%
Profit Quality 163.37%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACC6.24%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)144.44%
Profit Quality(5y)197%
High Growth Momentum
Growth
EPS 1Y (TTM)1.29%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%-30.43%
EPS Next Y-2.56%
EPS Next 2Y7.69%
EPS Next 3Y11.02%
EPS Next 5Y10.99%
Revenue 1Y (TTM)20.58%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%24.11%
Revenue Next Year-10.4%
Revenue Next 2Y-2.8%
Revenue Next 3Y0.65%
Revenue Next 5Y2.61%
EBIT growth 1Y291.07%
EBIT growth 3Y-25.44%
EBIT growth 5Y34.3%
EBIT Next Year-5.93%
EBIT Next 3Y-0.33%
EBIT Next 5YN/A
FCF growth 1Y-47.72%
FCF growth 3Y-4.39%
FCF growth 5Y-2.53%
OCF growth 1Y-47.72%
OCF growth 3Y-4.39%
OCF growth 5Y-2.53%

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 / CRBD FAQ

Can you provide the ChartMill fundamental rating for COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64?

ChartMill assigns a fundamental rating of 4 / 10 to CRBD.


Can you provide the valuation status for COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64?

ChartMill assigns a valuation rating of 6 / 10 to COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD). This can be considered as Fairly Valued.


How profitable is COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) stock?

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for CRBD stock?

The Earnings per Share (EPS) of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) is expected to decline by -2.56% in the next year.


How sustainable is the dividend of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) stock?

The dividend rating of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) is 3 / 10 and the dividend payout ratio is 52.57%.